Physcion 8-O-β-glucopyranoside exhibits anti-leukemic activity through targeting sphingolipid rheostat.

Han J, Zhao P, Shao W, Wang Z, Wang F, Sheng L

Open source

DOI
10.1016/j.pharep.2018.03.003
Published
2018 Oct
Container
Pharmacological reports : PR
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.pharep.2018.03.003,
  title = {Physcion 8-O-β-glucopyranoside exhibits anti-leukemic activity through targeting sphingolipid rheostat.},
  author = {Han J and Zhao P and Shao W and Wang Z and Wang F and Sheng L},
  year = {2018},
  journal = {Pharmacological reports : PR},
  doi = {10.1016/j.pharep.2018.03.003},
  url = {https://doi.org/10.1016/j.pharep.2018.03.003}
}

RIS

TY  - JOUR
TI  - Physcion 8-O-β-glucopyranoside exhibits anti-leukemic activity through targeting sphingolipid rheostat.
AU  - Han J
AU  - Zhao P
AU  - Shao W
AU  - Wang Z
AU  - Wang F
AU  - Sheng L
PY  - 2018
JO  - Pharmacological reports : PR
DO  - 10.1016/j.pharep.2018.03.003
UR  - https://doi.org/10.1016/j.pharep.2018.03.003
ER  - 

APA

J, H., P, Z., W, S., Z, W., F, W., & L, S. (2018). Physcion 8-O-β-glucopyranoside exhibits anti-leukemic activity through targeting sphingolipid rheostat.. Pharmacological reports : PR. https://doi.org/10.1016/j.pharep.2018.03.003

Source records